Coastlands Capital LP

Coastlands Capital LP is listed in filings as 10% Owner at Pasithea Therapeutics Corp.. This profile follows SEC Form 4 activity through Jun 22, 2026, including purchase activity. Recent filings connect the profile to Pasithea Therapeutics Corp. (KTTA) and Eloxx Pharmaceuticals, Inc. (ELOX). The current snapshot covers public activity from May 29, 2026 to Jun 22, 2026. Reported amounts are shown as $53.0K to $12.5K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.